A.forall

A.forall is a pharmaceutical company and licensing and distribution partner focused on making affordable medicines available to all. With more than 18 years of experience, the A.forall Group works across the pharmaceutical value chain, drawing on expertise, agility, and flexibility to help address gaps in the industry. Its portfolio includes more than 35 molecules marketed in Europe and the United States, and the company has signed over 250 distribution and licensing deals with leading pharmaceutical companies.

A.forall’s mission centers on ensuring patients have equal access to medicines and continuity of treatment. The company emphasizes quality and safety, aiming to help patients receive treatment without interruption. Its work is guided by an ambition to support a more sustainable world, with environmental, social, and governance considerations described as part of its DNA. A.forall also invites prospective partners to collaborate in advancing innovation and quality throughout the pharmaceutical value chain. The company shares updates on its activities, including developments in its generic injectables portfolio, and provides career opportunities for people interested in contributing to its mission.